EXercise Training for the Prevention of Cancer Thrombosis (EXPECT) Pilot Trial

Completed · Not applicable

Conditions studied: Cancer Thrombosis

In brief

Patients with lymphoma or cancer who are receiving chemotherapy in the outpatient setting are at risk for blood clots which form in the veins. The occurrence of blood clots has major implications on personal health including the need for blood thinners and monitoring, potential bleeding, and complications related to blood clots on cardiovascular health. The goal of this study is to determine whether aerobic exercise training is a therapeutic strategy to offset risk of blood clots and improve quality of life among cancer patients during chemotherapy.

Key facts

Study ID

NCT01853202

Run by

University of Vermont

People needed

40

Starts

2013-03-01

Last updated by the study team

2014-12-04

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of lymphoma or cancer
• Beginning chemotherapy regimen
• Patient self-report of ability to walk 10 minutes without interruption or pain
• Age >18 and <80
• Willingness to participate in the oncology rehabilitation program at Tilley Drive South Burlington

You may not qualify if…

• Presence or history of DVT or PE prior to entry
• Antithrombotic therapy including warfarin, dabigatran, low molecular weight heparin or unfractionated heparin which will alter levels of hemostatic factors (Off Lovenox 48 hours before first study blood draw)
• Medical condition that alters ability to walk for exercise

Where it is running

• Fletcher Allen Healthcare — Burlington, Vermont, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.